2Yang W,Gao Y,Liu G,et al.Biphasic insulin aspart 30 as inslininitiation or replacement therapy:the China cohort of the IMPROVE study[J].Curr Med Res Opin,2010,26:101-107.
3Baetta R,Corsini A.Pharmacology of dipeptidyl peptidase-4 inhibitors:similarities and differences[J].Drugs,2011,71(11):1441-1467.
4Muscelli E,Casolaro A,Gastaldelli A,et al.Mechanisms for the antihyperglyeemic effect of sitagliptin in patients with type 2 diabetes[J].J Clin Endocrinol Metab,2012,97(8):2818-2826.
5Takeda Y,Fujita Y,Honlo J,et al.Reduction of both betacelldeath and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice[J].Diabetologia,2012,55(2):404-412.
6Yeom JA,Kim ES,Park HS,et al.Both sitagliptin analogue&pioglitazone preserve the beta-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice[J].BMB Rep,2011,44(11):713-718.
